SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000880771-14-000042
Filing Date
2014-11-10
Accepted
2014-11-10 16:58:48
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scln-20140930x10q.htm 10-Q 1613580
2 EX-31.1 scln-20140930ex3117d4c9e.htm EX-31.1 18584
3 EX-31.2 scln-20140930ex312f7a0d9.htm EX-31.2 18598
4 EX-32.1 scln-20140930ex3216a2d1d.htm EX-32.1 12795
5 EX-32.2 scln-20140930ex3220548de.htm EX-32.2 14657
  Complete submission text file 0000880771-14-000042.txt   7564676

Data Files

Seq Description Document Type Size
6 EX-101.INS scln-20140930.xml EX-101.INS 1261042
7 EX-101.SCH scln-20140930.xsd EX-101.SCH 37553
8 EX-101.CAL scln-20140930_cal.xml EX-101.CAL 47901
9 EX-101.DEF scln-20140930_def.xml EX-101.DEF 94260
10 EX-101.LAB scln-20140930_lab.xml EX-101.LAB 273291
11 EX-101.PRE scln-20140930_pre.xml EX-101.PRE 235043
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 141209471
SIC: 2834 Pharmaceutical Preparations